The median progression free survival, increased from 19.2 months to 35.7 months when Sarclisa was added to carfilzomib and dexamethasone
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
India has the second-largest number of adults with diabetes globally, after China
Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19
The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams
The campaign will be available in nine Indian languages namely Hindi, English, Odia, Marathi, Tamil, Telugu, Kannada, Malayalam and Bengali
Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India
The production suspension impacts commercial and clinical trial supply
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The EBUS is designed to support the diagnosis and staging of various lung disorders
Subscribe To Our Newsletter & Stay Updated
